ISSN: 1449-2288International Journal of Biological Sciences
Global reach, higher impact
Int J Biol Sci 2016; 12(12):1437-1447. doi:10.7150/ijbs.16529 This issue Cite
Research Paper
MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1
1. Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University
140 Hanzhong Road, Nanjing 210029, P.R. China.
2. Department of Molecular Cell Biology and Toxicology, School of Public Health, Nanjing Medical University
140 Hanzhong Road, Nanjing 210029, P.R. China.
3. Laboratory of Cancer Biology, Biomedical Research Center, Sir Runrun Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China.
Citation:
Zhang Y, Xu W, Ni P, Li A, Zhou J, Xu S. MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1. Int J Biol Sci 2016; 12(12):1437-1447. doi:10.7150/ijbs.16529. https://www.ijbs.com/v12p1437.htm
Other stylesAbstract
Cisplatin is the first-line agent utilized for the clinical treatment of a wide variety of solid tumors including gastric cancer. However, the intrinsic or acquired cisplatin resistance is often occurred in patients with gastric cancer and resulted in failure of cisplatin therapy. In order to investigate if miRNA involves in cisplatin resistance of human gastric cancer, we first screened and compared the expression of miRNAs between cisplatin resistant gastric cancer cell lines SGC-7901/DDP and BGC-823/DDP and their sensitive parental cells by miRNAs microarray and followed by analysis of 2D-GE/MS to identify their target proteins. We found both miR-99a and miR-491 were upregulated while their target gene calpain small subunit 1 (CAPNS1) was downregulated in resistant gastric cancer cells. Dual-luciferase- reporter assays with wild-type and mutated CAPNS1 3'-UTR confirmed their specificity of targeting. Inhibition of miR-99a and miR-491, or overexpress CAPNS1 can enhance cisplatin sensitivity of the resistant cells while transfection of two miRNAs' mimics or si-CAPNS1 in the sensitive cells can induce their resistance. Moreover, our results demonstrated CAPNS1 positively regulated calpain1 and calpain2, the catalytic subunits of CAPNS1, and cleaved caspase3 which further cleaved PARP1 and directly induced apoptosis. Therefore, miR-99a and miR-491 might be work as novel molecules regulate cisplatin resistance by directly targeting CAPNS1 associated pathway in human gastric cancer cells.
Keywords: miR-99a, miR-491, CAPNS1, cisplatin resistance, gastric cancer.
Citation styles
APA
Zhang, Y., Xu, W., Ni, P., Li, A., Zhou, J., Xu, S. (2016). MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1. International Journal of Biological Sciences, 12(12), 1437-1447. https://doi.org/10.7150/ijbs.16529.
ACS
Zhang, Y.; Xu, W.; Ni, P.; Li, A.; Zhou, J.; Xu, S. MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1. Int. J. Biol. Sci. 2016, 12 (12), 1437-1447. DOI: 10.7150/ijbs.16529.
NLM
Zhang Y, Xu W, Ni P, Li A, Zhou J, Xu S. MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1. Int J Biol Sci 2016; 12(12):1437-1447. doi:10.7150/ijbs.16529. https://www.ijbs.com/v12p1437.htm
CSE
Zhang Y, Xu W, Ni P, Li A, Zhou J, Xu S. 2016. MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1. Int J Biol Sci. 12(12):1437-1447.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.